Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Expanded Access to Trametinib for a child with Plexiform Neurofibroma in NF1

Disease Sites:

Pediatrics

Staging:

N/A

Age Group:

Children

Therapies:

Mol. targeted/Immunotherapy/Biologics

Drugs:

Trametinib

Principal Investigator(s):

Esbenshade, Adam

Scope:

Local

Participating Institutions:

Vanderbilt University

Open Date:

08-24-2022

Trial Type:

Other

Protocol ID:

VICCPED2251

Related Internal Documents:

View Internal Documents

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available